NCT07493850

Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals

• Status: Active Not Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Circul'Egg · Industry
• Sex: All
• Age: 30 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical study is to evaluate the efficacy and tolerability of EMC-CAP-2025A, an eggshell membrane-based dietary supplement, on age-related skin parameters in healthy adults. The main questions this study aims to answer are: * Does daily supplementation with EMC-CAP-2025A improve facial wrinkles compared to placebo? * Does EMC-CAP-2025A improve skin hydration, firmness, elasticity, texture, and overall skin quality? * Is EMC-CAP-2025A well tolerated when taken daily for 60 days? Researchers will compare EMC-CAP-2025A to a placebo to assess its effects on multiple skin parameters using objective instrumental assessments and participant self-evaluations. Participants will: * Be randomly assigned to receive either EMC-CAP-2025A or a placebo * Take one capsule orally once daily for 60 days * Attend scheduled study visits at baseline, Day 30, and Day 60 for instrumental skin assessments and safety evaluations * Complete self-assessment questionnaires related to skin quality and product tolerability

Conditions

• Facial Wrinkles
• Skin Hydration
• Skin Elasticity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	EMC-CAP-2025A	EMC-CAP-2025A 300 mg per capsule Regimen: 1 capsule per day after meals Route: Oral Duration: 60 days
DIETARY_SUPPLEMENT	EMC-CAP-2025B	Placebo

Timeline

• Start date: 2026-02-27
• Primary completion: 2026-05-26
• Completion: 2026-05-26
• First posted: 2026-03-25
• Last updated: 2026-04-02

Locations

1 site across 1 country: India